TrialAnnals of the rheumatic diseases2018

Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.

Christopher P Denton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.